Blocking ligand occupancy of the αVβ3 integrin inhibits the development of nephropathy in diabetic pigs
about
An Update on the Use of Animal Models in Diabetic Nephropathy ResearchHorizon 2020 in Diabetic Kidney Disease: The Clinical Trial Pipeline for Add-On Therapies on Top of Renin Angiotensin System BlockadeSoluble Urokinase Receptor and the Kidney Response in Diabetes Mellitus.Blocking αVβ3 integrin ligand occupancy inhibits the progression of albuminuria in diabetic rats.Soluble Urokinase Receptor and Chronic Kidney Disease.Changes in podocyte TRPC channels evoked by plasma and sera from patients with recurrent FSGS and by putative glomerular permeability factors.Nanomedicines for renal disease: current status and future applicationsTargeting inflammation in diabetic kidney disease: early clinical trials.Novel avenues for treating diabetic nephropathy: new investigational drugs.Soluble Urokinase Plasminogen Activator Receptor and Outcomes in Patients with Diabetes on Hemodialysis.An integrin antagonist (MK-0429) decreases proteinuria and renal fibrosis in the ZSF1 rat diabetic nephropathy model.Cardiovascular Disease Biomarkers and suPAR in Predicting Decline in Renal Function: A Prospective Cohort Study.Molecular mechanisms involved in podocyte EMT and concomitant diabetic kidney diseases: an update.Actin dynamics at focal adhesions: a common endpoint and putative therapeutic target for proteinuric kidney diseases.Patent highlights August-September 2016.
P2860
Q26774178-E1F530FB-749A-4C5C-B3F6-BEB44D802AC6Q26799443-2097FAEA-38EE-4548-B0FE-DA97EE69ED70Q33741426-A379ECCA-28F0-4621-BC42-C6BC913BB7E6Q34441673-3AEAAF13-AD63-4482-953E-F4F936E8019AQ36429637-453EC64D-9AB9-42DA-8722-82960AD79D1AQ38718670-447D32BA-344D-4BAB-9748-318B8730EA60Q38802375-07F9CD23-48A4-4E8C-959A-34BA254CAF9BQ38857166-67A8435D-07FC-43B4-A070-FABBACE5B9B5Q39170387-C9AF00CA-3C84-4E96-9F8D-EFF7113DE671Q40216229-2957533A-5639-469B-9CD5-69A98EB3BCC1Q42285693-100E8460-BFBE-4934-8FD9-D91BDA58DB7EQ44256854-E87CBDEF-A912-456D-9969-54AA0E691655Q51055209-4651274E-40D6-41D5-9D8E-7611B81667C9Q52573827-5E5252A9-AD35-49F7-AB4B-915176B475A6Q54076993-2C297777-A493-47AA-AEF3-C4402A03C7AA
P2860
Blocking ligand occupancy of the αVβ3 integrin inhibits the development of nephropathy in diabetic pigs
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Blocking ligand occupancy of t ...... f nephropathy in diabetic pigs
@ast
Blocking ligand occupancy of t ...... f nephropathy in diabetic pigs
@en
Blocking ligand occupancy of t ...... f nephropathy in diabetic pigs
@nl
type
label
Blocking ligand occupancy of t ...... f nephropathy in diabetic pigs
@ast
Blocking ligand occupancy of t ...... f nephropathy in diabetic pigs
@en
Blocking ligand occupancy of t ...... f nephropathy in diabetic pigs
@nl
prefLabel
Blocking ligand occupancy of t ...... f nephropathy in diabetic pigs
@ast
Blocking ligand occupancy of t ...... f nephropathy in diabetic pigs
@en
Blocking ligand occupancy of t ...... f nephropathy in diabetic pigs
@nl
P2093
P2860
P356
P1433
P1476
Blocking ligand occupancy of t ...... f nephropathy in diabetic pigs
@en
P2093
Amit Patel
David Clemmons
Dwight Bellinger
Kara Stewart
Katherine A Gollahon
Laura A Maile
Matt Medlin
Nikol Garbacik
Paul Dunbar
Stefani Garbacik
P2860
P304
P356
10.1210/EN.2014-1318
P407
P577
2014-08-29T00:00:00Z